KLP Kapitalforvaltning’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$535K Buy
4,900
+300
+7% +$28.6K ﹤0.01% 1395
2025
Q4
$373K Buy
4,600
+200
+5% +$17.2K ﹤0.01% 1557
2025
Q3
$385K Hold
4,400
﹤0.01% 1533
2025
Q2
$365K Buy
4,400
+600
+16% +$50.1K ﹤0.01% 1503
2025
Q1
$319K Sell
3,800
-5,000
-57% -$465K ﹤0.01% 1534
2024
Q4
$811K Buy
+8,800
New +$846K ﹤0.01% 1085

Other funds holding LMAT

KLP Kapitalforvaltning's LMAT Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its LeMaitre Vascular (LMAT) stake by 6.5% in Q1 2026, buying an estimated $28.6K and bringing the position to 4,900 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #1395.

KLP Kapitalforvaltning first reported a position in LMAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $811K in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • KLP Kapitalforvaltning held 4,900 shares of LeMaitre Vascular worth $535K as of Q1 2026.
  • KLP Kapitalforvaltning bought 300 LeMaitre Vascular shares in Q1 2026, an estimated $28.6K.
  • LeMaitre Vascular made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1395 holding.
  • KLP Kapitalforvaltning first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's LeMaitre Vascular position peaked at $811K in Q4 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.